Veraxa Biotech AG - Post de-SPAC
VRXAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002079109
In the last 90 days, Veraxa Biotech AG - Post de-SPAC insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $992.5K in total; no superinvestor holds it.
Other share classesVRXA
Q2 2026 vs. Q1 2026
How the institutions holding Veraxa Biotech AG - Post de-SPAC changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 0 | 27 | +27 |
| Shares | 0 | 8.54M | +8.54M |
| Value | $0 | $992.5K | +$992.5K |
New holders (27)
Institutions that held Veraxa Biotech AG - Post de-SPAC at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (0)
Institutions that held Veraxa Biotech AG - Post de-SPAC at the end of Q1 2026 and filed for Q2 2026 without it.
None.